Aptar Reports Fourth Quarter And Annual Results Recaps Year Of Pharma

Aptar Reports Fourth Quarter And Annual 2022 Results Aptar The fourth quarter effective tax rate on adjusted earnings was 28% compared to 29% in the prior year. annual results. for the year ended december 31, 2019, reported sales increased approximately 3% to $2.9 billion from $2.8 billion a year ago. Aptar reported net income of $62 million for the quarter, a 6% increase over the prior year. “i am pleased to report that we delivered strong fourth quarter and full year results. in 2023, we achieved year over year double digit earnings per share growth, an increase of net income of almost 20% and a 15% increase in adjusted ebitda.

Aptar Reports Fourth Quarter And Annual Results Recaps Year Of Pharma Annual 2019 summary. reported sales increased 3%. core sales, excluding currency and acquisition effects, grew 3%. reported earnings per share of $3.66 (up 22% compared to the prior year) adjusted earnings per share of $3.95 (up 2% compared to the prior year) reported net income of $242 million (up 24% compared to the prior year). Aptargroup, inc. (nyse:atr), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported fourth quarter and annual results for 2021. photo: aptar fourth quarter 2021 summary strong top line growth across each segment resulted in reported sales up 9% and core sales (excluding currency effects and acquisitions) up 10% reported. Aptar reported net income of $62 million for the quarter, a 6% increase over the prior year. "i am pleased to report that we delivered strong fourth quarter and full year results. in 2023, we. Fourth quarter 2022 summary. reported sales decreased 2% and net income increased 2% to $59 million. core sales increased 4% and adjusted ebitda of $147 million decreased 4% from the prior year. core sales growth in the quarter was driven by strong volume growth in pharma and beauty, as well as price increases in the beauty home segment.

Aptar Reports Fourth Quarter And Annual 2023 Results Pharmiweb Aptar reported net income of $62 million for the quarter, a 6% increase over the prior year. "i am pleased to report that we delivered strong fourth quarter and full year results. in 2023, we. Fourth quarter 2022 summary. reported sales decreased 2% and net income increased 2% to $59 million. core sales increased 4% and adjusted ebitda of $147 million decreased 4% from the prior year. core sales growth in the quarter was driven by strong volume growth in pharma and beauty, as well as price increases in the beauty home segment. Aptargroup, inc., a global leader in consumer dispensing, active packaging and drug delivery solutions and services, today reported its fourth quarter and full year 2019 financial results. Aptar reported fourth quarter earnings per share of $0.93, an increase of 4%, compared to $0.89 during the same period a year ago. fourth quarter adjusted earnings per share, excluding restructuring charges and the unrealized gains or losses on an equity investment, were $1.21, an increase of 27%, compared to $0.95 in the prior year, including.